Cell and matrix composites recently have been used to repair tendons and li
gaments. In the current study the authors briefly review prior studies in t
his area, and the contributions these findings have made toward solving thi
s clinical problem. The authors then provide a perspective on the necessary
characteristics that the cells and delivery vehicles of these composites m
ust possess, separately and in combination, to function successfully after
surgery. The authors conclude by applying these functional tisue engineerin
g principles to two tendon injury models in which mesenchymal stem cells ha
ve been suspended in Type I collagen gel to form composites for patellar an
d Achilles tendon repair. In the first study, mesenchymal stem cells were s
uspended in gel (5 million cells/mL) with no attempt to align the cells dur
ing incubation. The resulting composites were implanted in window defects i
n one patellar tendon in the rabbit knee, with gel alone in a matching defe
ct on the contralateral side. Biomechanical evaluation at 4 weeks showed th
at the material properties of the mesenchy-mal stem cell based repairs were
18% to 33% greater than results for contralateral controls. In the second
study, mesenchymal stem cells were suspended in gel (4 million cells/mL), c
ontracted on a tensioned suture during incubation, placed in an Achilles ga
p defect, and compared,vith repairs of contralateral gap injuries containin
g suture alone (controls), By 4 weeks, the repairs treated 7 with mesenchym
al stem cells had achieved twice the structural properties of the contralat
eral controls and 50% to 60% of the stiffness and strength of normal tendon
s that were not surgically treated. In addition, the material properties of
the repairs treated with. mesenchymal stem cells had increased with time t
o 37% of normal by 12 weeks after surgery. Both studies reveal the benefits
of using pluripotential cells in a collagen gel matrix, and suggest additi
onal research that might enhance the repair quality of healing tendons.